Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Europe Biomarkers Market is estimated to reach USD 19.07 billion by 2023 | Market Data Forecast

Biomarkers are found commonly in body fluids and tissues. Biomarkers are helpful in drug discovery.........
Zain Ahmed | 10.10.2018
Market Data Forecast © Zain Ahmed

Biomarkers are also known as the biological molecules or genes help in vital clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and employed to examine the pharmacologic responses, biological & pathological conditions. Biomarkers are found commonly in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.

View sample and decide:

Market views:

Europe biomarkers market is estimated to reach USD 19.07 billion by 2023 from USD 10.39 billion in 2018 growing at a CAGR of 12.9%.

Drivers and restraints:

The drivers which are influencing the growth of Biomarkers market in Europe are rising healthcare expenditure, growing aging population, increasing number of cancer patients, increasing demand for diagnostics, rising consciousness on healthy lifestyle. In addition, increasing utilization of biomarkers in clinical trials & drug discovery and enhancing technologies in biomarkers discovery are further stimulating the growth of biomarkers market in Europe.

The restraints which are limiting the growth of biomarkers market are need of qualitative biomarkers validation and high cost of the biomarkers development.

For the detailed information please follow the link:

Partition of the Market:

Europe biomarkers market is partitioned according to product, type, application, and disease indications. With respect to product, the market is further sub-divided as consumables, software, and services. With respect to type, the market is classified into safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further categorized into diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. With respect to disease indications, the market is classified into cancer, cardiovascular, neurological, and immunological disorders.

Geographically the Europe biomarkers market is partitioned into U.K., Germany, France, Italy, and Spain.

View the customized report here:

Key players of the market:

The prominent players in biomarkers market are Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).

Scope of the Report:

The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.

The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.

What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.